你目前无法使用部分二次筛选功能
请联系客服开通更多权限和功能！
| 申请号 | 申请类型 | 商品名 | 活性成分 | 中文活性成分 | 剂型/给药途径 | 批准日期 | 申请机构 |
|---|---|---|---|---|---|---|---|
| 761425 | BLA | PYZCHIVA | USTEKINUMAB-TTWE | INJECTABLE;SUBCUTANEOUS | 2024-06-28 | SAMSUNG BIOEPIS CO LTD | |
| 761388 | BLA | PIASKY | CROVALIMAB-AKKZ | INJECTABLE;INTRAVENOUS | 2024-06-20 | GENENTECH INC | |
| 761378 | BLA | AHZANTIVE | AFLIBERCEPT | 阿柏西普 | INJECTABLE;INJECTION | 2024-06-28 | FORMYCON AG |
| 761373 | BLA | PYZCHIVA | USTEKINUMAB-TTWE | INJECTABLE;INJECTION | 2024-06-28 | SAMSUNG BIOEPIS CO LTD | |
| 761363 | BLA | WINREVAIR | SOTATERCEPT-CSRK | INJECTABLE;INJECTION | 2024-03-26 | MERCK SHARP DOHME | |
| 761362 | BLA | JUBBONTI | DENOSUMAB-BBDZ | INJECTABLE;SUBCUTANEOUS | 2024-03-05 | SANDOZ INC | |
| 761359 | BLA | ENTYVIO | VEDOLIZUMAB | 维多珠单抗 | INJECTABLE;INTRAVENOUS | 2024-04-18 | TAKEDA PHARMS USA |
| 761358 | BLA | ZYMFENTRA | INFLIXIMAB-DYYB | 英利昔单抗-DYYB | INJECTABLE;INJECTION | CELLTRION | |
| 761355 | BLA | EYLEA HD | AFLIBERCEPT | 阿柏西普 | INJECTABLE;INJECTION | REGENERON PHARMACEUTICALS | |
| 761354 | BLA | TOFIDENCE | TOCILIZUMAB-BAVI | 托珠单抗 | INJECTABLE;INJECTION | 2023-09-29 | BIOGEN MA |
| 761350 | BLA | OPUVIZ | AFLIBERCEPT-YSZY | INJECTABLE;INJECTION | 2024-05-20 | SAMSUNG BIOEPIS CO LTD | |
| 761349 | BLA | COSENTYX | SECUKINUMAB | 瑟库吉努单抗 | INJECTABLE;INJECTION | NOVARTIS PHARMS CORP | |
| 761346 | BLA | HERCESSI | TRASTUZUMAB-STRF | INJECTABLE;INJECTION | 2024-04-25 | ACCORD BIOPHARMA INC. | |
| 761345 | BLA | ELREXFIO | ELRANATAMAB | 埃纳妥单抗 | SOLUTION;INJECTION | 2023-08-14 | PFIZER INC |
| 761344 | BLA | IMDELLTRA | TARLATAMAB-DLLE | INJECTABLE;INJECTION | 2024-05-16 | AMGEN INC | |
| 761343 | BLA | SELARSDI | USTEKINUMAB-AEKN | INJECTABLE;INJECTION | 2024-04-16 | ALVOTECH USA INC | |
| 761342 | BLA | TALVEY | TALQUETAMAB-TGVS | 塔奎妥单抗 | INJECTABLE;INJECTION | 2023-08-09 | JANSSEN BIOTECH |
| 761340 | BLA | EPYSQLI | ECULIZUMAB-AAGH | INJECTION;SOLUTION | 2024-07-19 | SAMSUNG BIOEPIS CO LTD | |
| 761339 | BLA | VEOPOZ | POZELIMAB-BBFG | 帕泽利单抗 | INJECTABLE;INJECTION | 2023-08-18 | REGENERON PHARMACEUTICALS |
| 761336 | BLA | ANKTIVA | nogapendekin alfa inbakicept-pmln | SOLUTION;INTRAVESICAL | 2024-04-22 | ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU |
